bf/NASDAQ:ILMN_icon.jpeg

NASDAQ:ILMN

Illumina Inc

  • Stock

USD

Last Close

139.83

01/03 21:00

Market Cap

22.33B

Beta: 1.18

Volume Today

1.87M

Avg: 1.23M

PE Ratio

−19.97

PFCF: 133.64

  • industry

    Diagnostics & Research
  • exchange

    NASDAQ Global Select
  • website

    www.illumina.com
  • ipo date

    Jul 28, 2000
  • full time employees

    11,500
  • currency

    USD

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive he...Show More

founders

  • David R. Walt
  • John Stuelpnagel
  • Larry Bock
  • Satnam Alag

num employees

  • 5001-10000

recent investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$9MSeries A - Mantra Bio04-01-2023Mantra Bio
Pre Seed Round - Mable (Neurolytic Healthcare)27-07-2022Mable (Neurolytic Healthcare)
$375MPost-IPO Equity - SomaLogic01-09-2021SomaLogic
£499.8KPre Seed Round - Concr01-04-2021Concr
$70MSeries F - Ginkgo Bioworks28-05-2020Ginkgo Bioworks
$390MSeries D - Grail06-05-2020Grail
$200MVenture Round - Helixis01-03-2018Helixis
$200MSeries B - Helix01-03-2018Helix
$2.8MSeed Round - Prospect Bio15-11-2016Prospect Bio
$2MSeed Round - VitageneNo17-02-2016Vitagene

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.